company orange = changed from original graphic RBS Microsoft Johnson & Johnson (2012)* Barclays HSBC Standard

Chartered UBS HSBC UBS GlaxoSmithKline Abbott Laboratories Amgen Boehringer Ingelheim Lloyds Banking Group BP AstraZeneca GlaxoSmithKline Halliburton UBS Eli Lilly & Co Pfizer Intel Exxon Mobil Siemens A.G. Merck Boeing Shell A.I.G Prudential Financial Bank Of America Time Warner Serono Laboratories Royal Ahold Samsung

nominal fine $m $m 612 731 2,200 450 1,920 634 1,500 2,300 45 3,000 1,500 762 95 5 34,000 520 750 579 788 1,420 2,300 1,450 507 1,600 950 615 1,500 1,600 600 676 2,400 704 1,100 300

inflationadjusted year based on (of US 2013 612CPI, 2013 731 2012 2230.46 2012 456.23 2012 1946.58 2012 643.07 2012 1520.77 2012 2331.85 2012 46.02 2012 3041.54 2012 1520.77 2012 772.55 2012 96.32 2011 5.53 2010 36294.72 2010 555.1 2010 800.62 2009 628.22 2009 854.98 2009 1540.7 2009 2495.5 2009 1573.25 2008 548.14 2008 1729.83 2007 1066.52 2006 710.1 2006 1731.94 2006 1847.4 2006 692.78 2005 805.71 2005 2860.5 2005 839.08 2005 1311.06 2005 357.56

detail graphic here: http://www.informationisbeautiful.net/2012/punytivedamages-biggest-corporate-fines/ Libor rigging: traders found to be illegally altering interest rates to generate profits for the bank and to appear more financially sound Failed to offer users a choice of web browser. This is an unprecedented sanction that will act as a warning to other firms. Illegally marketed and failed to warn of side effects for antipsychotic Risperdal & Invega and Natrecor, unlisted Libor rigging: drugs traders found to be illegally altering interest ratesside to generate profits for the bank and to appear more financially sound Helped Mexican drug barons launder money through the financial system. Hid $250bn worth of transactions that left the financial system vulnerable to "terrorists" and "drug kingpins" in the six years up to to Libor rigging: traders found to be illegally altering interest rates generate payment profits for the bank insurance. and to appear more financially sound Mis-sold protection

net income (year of fine $M -5,971 15,460 9,672 9,124 13,454 4,786 -2,658 13,454 After Kweku Adoboli caused 'substantial losses' totaling US$2.3 -2,658 billion. fraud, illegal sales practices related to nine drugs, and Medicaid 8,182 also product liability cases drug over Depakote its marketing of theunapproved diabetes drug Promoted the anti-seizure for uses by 4,728 the U.S.introduced Food and Drug Administration. Illegally and promoted several drugs including Aranesp, 4,345 a drug to treat anemia. Promoted several drugs for non- medically accepted uses 1,237 Mishandled complaints by wrongly rejecting 45% of grievances -4,249 relating to its retail investment products. Gulf of Mexico oil spill -3,324 Illegally marketed the anti-psychotic drug Seroquel for uses not 8,110 approved as safe effective by the drug US Food and Drug Manufactured andand sold contaminated products to Medicaid 5,466 and other government health plans. Bribing officials in Nigeria. 1,145 Sham accounts, destroying documents, tax evasion. 2,224 Illegally marketing an anti-psychotic drug (zyprexa) for uses not 4,330 approved by the painkiller FDA. Misbranding Bextra, promoting it for unsuitable uses 8,640 Paying manufacturers to favour its products over those of rivals. 4,400 Exxon Valdez Oil Spill off coast of Alaska. Punitive damages 45,220 reduced after appeal, see notes. For paying "kickbacks and bribes to win contracts from Iraq's 8,182 government in 'Vioxx' the United Nations oil-for-food program and for Selling a drug causing some users to suffer heart 3,280 attacks/ischemic strokes. Contracting scandals. Illegally hiring a senior Air Force official to 2,215 win contracts and to have improperly Damage to land infound the Niger Delta, Nigeria. acquired sensitive 26,300 Improper accounting, bid-rigging and skipped payments to state 14,048 workers' compensation funds.Prudential Financial is not associated 3,430 Deceptive trading (US based with UK corporation Prudential plc) Allowed a select group of traders to make 'improper trades', 16,465 including trading after the 4pm market close. Deceiving investors about the details of a merger with AOL. 1,253 Fraud & kickbacks - illegal marketing of AIDS wasting drug 570 Serostim and illegal remuneration/incentives paid to doctors to Accounting fraud 293 International price fixing for the computer part, DRAM (dynamic 9,400 random access memory).

fine as % of net income year of fine -10.25% 4.73% 22.75% 4.93% 14.27% 13.25% -56.44% 17.10% -1.71% 36.66% 31.73% 17.54% 7.68% -0.13% -1022.86% 6.41% 13.72% 50.57% 35.43% 32.79% 26.62% 32.95% 1.12% 19.56% 28.96% 27.77% 5.70% 11.39% 17.49% 4.11% 191.54% 123.51% 375.43% 3.19%

company sector finance tech pharma finance finance finance finance finance finance pharma pharma pharma pharma finance energy pharma pharma defence finance pharma pharma tech energy tech pharma defence energy finance finance finance media pharma retail tech

years of crime dates 2006 - 2010 2011 - 2012 1998 - 2003 2005 - 2009 2004 - 2010 2001 - 2007 2005 - 2010 2001 - 2011 2006 - 2011 1994-2007 1998-2006 since 2007 no data 2007 - 2009 2010 2001-2006 2001 - 2005 1994 - 2004 2001 - 2006 1999-2001 2001 - 2005 2002 - 2007 1989 1995-2007 2004 1998-2003 2000 1991 - 2004 2001-2003 1998 - 2003 1999 - 2002 1997-2001 2001-2002 1999-2002

years of crime crime category duration, : corruption (inc. years fraud & mis-selling) 4 corruption: fraud 1 anti-competitive 5 corruption: misselling 4 corruption: fraud 6 corruption: fraud 6 corruption: fraud 5 corruption: fraud 10 corruption: misselling 5 error 13 8 0 5 4 10 5 2 4 5 0 12 0 5 0 13 2 5 3 4 1 3 corruption corruption: misselling corruption: misselling corruption: misselling error corruption: misselling error corruption corruption: fraud corruption: misselling corruption: misselling corruption error corruption corruption: misselling corruption error corruption: fraud corruption: fraud corruption corruption: fraud corruption: misselling corruption: fraud corruption: fraud

time delay: years from 7 2 14 7 8 11 7 11 6 18 14 5 0 9 9 15 10 10 8 7 19 13 3 8 6 15 5 7 6 8 4 6

time delay: years from 2 1 9 3 2 5 2 1 1 5 6 0 4 5 5 3 8 4 2 19 1 3 3 6 2 3 2 3 4 3 3

net income (year as onof 4- fine) traders -5,971 16,978 10,853 -1,590 13,454 4,786 -2,658 13,454 -2,658 4,565 5,963 4,345 -4,249 -3,324 8,053 1,634 -

operating profit as on (year 4traders 11,168 27,956 20,308 10,549 25,403 8,785 3,318 25,403 3,318 8,330 9,833 6,517 no data 31,740 13,603 9,129 -

operating income as on 4traders 12,792 30,923 23,974 12,234 27,934 9,453 4,047 27,934 4,047 9,415 12,616 7,605 no data 42,904 15,258 11,200 -

link http://www.4-traders.com/ROYA http://www.4-traders.com/MICRO http://www.4-traders.com/JOHN http://www.4-traders.com/BARC http://www.4-traders.com/HSBC http://www.4-traders.com/STAN http://www.4-traders.com/UBS-A http://www.4-traders.com/HSBC http://www.4-traders.com/UBS-A http://www.4-traders.com/GLAX http://www.4-traders.com/ABBO http://www.4-traders.com/AMGE http://www.4-traders.com/LLOYD http://www.4-traders.com/BP-PL http://www.4-traders.com/ASTR http://www.4-traders.com/GLAX -

fined by

notes

fine $bn

revenue (years of $bn

net income (years of $bn

http://www.4-traders.com/ROYAL-BANK-OF-SCOTLAND-GR-10759239/financials/ EU http://www.4-traders.com/JOHNSON-JOHNSON-4832/financials/ J&J has agreed to up to $2.2 billion ($600m criminal penalty) 2.20 65.00 amounts to for less than of 10 percent of the Risperdal sales or $24 0.45 50.12 FSA Used 2011 years fine financials http://www.4-traders.com/HSBC-HOLDINGS-PLC-4001224/financials/ US regulators for breaking US sanctions on Iran & other countries US, UK and Swiss regulators http://www.4-traders.com/HSBC-HOLDINGS-PLC-4001224/financials/ FSA Mass litigation, Used 2011 for years of fine financials multiple suits. DOJ Used 2011 for years of fine financials US Justice Department http://www.4-traders.com/AMGEN-INC-4847/financials/ http://www.4-traders.com/LLOYDS-BANKING-GROUP-PLC-4000786/financials/ Various to cover Original net income figure (30,676) changed by Ella, 2013 compensation DOJ and Health and Human Civil settlement SEC US Investigators Office of Consumer Litigation of the of US Department Justice European 1.06bn euros, 948m Commission for anti- Punitive damages reduced from $5 billion to only $507.5 Supreme Court million after appeals that took place nearly 20 years after spill. US & German courts Separate federal Years of crimes 2004. and lawsuits U.S.state Departments of Justice, State, Nigerian National Assembly SEC SEC Securities and Exchange State Minnesota Board District of DOJ, of Massachusetts SEC & Dutch Law Enforcement DOJ 2006 - consolidated net income 2001 + 2002 revenues as AOL Time Warner (now merck) 3.00 42.60 1.50 38.85

9.67 9.12

8.18 4.73

34.00 0.52 0.75 0.58 0.79 1.42 2.30 1.45 0.51 1.60 0.95 0.62 1.50 1.60 0.60 0.68 2.40 0.70 1.10 0.30

308.93 33.27 41.04 14.68 23.66 21.84 50.01 35.10 459.58 107.64 24.20 61.53 318.85 113.19 24.85 56.09 8.81 2.59 56.94 140.90

30.68 8.11 5.47 1.15 2.22 4.33 8.64 4.40 45.22 8.18 3.28 2.22 26.30 14.05 3.43 16.47 1.25 0.57 0.29 9.40

revenue (years $bn ? of

net income (years $bn ? of

191.04 201.25

32.13 164.40

Chief sources Inflation adjustment: BLS Inflation BBC News; Guardian; RBS; 4-traders Reuters; Wiki Invest Bloomberg, Reuters Guardian Guardian; HSBC; 4traders; Reuters Guardian; Standard Chartered; 4-Traders City Wire; Reuters Guardian; HSBC; 4traders; BBC City Wire; BBC News New York Times, GSK Department of Justice, Get Filings Reuters; NY Times US gov; Boehringer Ingelheim; Bloomberg Independent; Guardian Guardian, BP Department of Justice, AstraZeneca CBS News, Get Nick Law Bloomberg, Halliburton, Getfilings Guardian, UBS MSNBC, Lilly Investor Relations Guardian, New York Times, Pfizer BBC, Intel NowPublic, New York Times, Thomson Washington Post, Siemens Boston Herald, Merck Endgame, Boeing Guardian, The Times, Shell York Times, AIG, New Securities Exchange Washington Post, Prudential New York Times, BankYork of America New Times, Get Filings Red Orbit, PRNewsWire, CNN, Ahold Department of Justice, Scribd, Samsung

377.27 150.40

93.77 22.98

308.93 124.76 173.87 135.82 209.99 32.41 203.60 96.08 1,034.02 7.97 274.15 191.51 583.82 53.82 206.87 22.93 5.46 110.67 105.72

30.68 23.38 37.48 0.37 43.53 8.56 38.25 3.81 38.12 0.42 9.10 12.72 59.87 1.30 49.44 -18.33 0.97 -0.44 15.62

Source Links http://www.bls.gov/data/inflation_calculator.htm http://www.bbc.co.uk/news/business-21356256 http://www.guardian.co.uk/business/2013/feb/06/royal-bank-of-sc http://www.investors.rbs.com/download/a http://uk.reuters.com/article/2013/03/06/us-eu-microsoft-idUSBRE92500520130306 http://www.wikinvest.com/stock/Microsoft_(MSFT)/Data/Net_Inco http://www.bloomberg.com/news/2012-06-11/j-j-said-to-pay-2-2-billion-to-end-risperdal-sa http://www.reuters.com/article/2012/06/08/johnsonandjohnson-ris http://www.searcymasstort.com/blog/2012 2012 http://www.guardian.co.uk/business/2012/jun/27/barclays-chief-b http://www.guardian.co.uk/business/2012 http://www.guardian.co.uk/business/2013/mar/04/hsbc-pay-top-earners http://www.hsbc.com/financialresults http://www.4-traders.com/HSBC-HOLDIN http://www.guardian.co.uk/business/2013/mar/28/standardchartered-executive-pay-bonu http://reports.standardchartered.com/annual-report-2012/financia http://www.4-traders.com/STANDARD-CH http://citywire.co.uk/wealth-manager/the-fsa-fines-which-rocked-financial-services-in-201 http://uk.reuters.com/article/2012/12/19/uk-ubs-libor-idUKBRE8B http://www.guardian.co.uk/business/2013/mar/04/hsbc-pay-top-earners http://www.hsbc.com/financialresults http://www.4-traders.com/HSBC-HOLDIN http://citywire.co.uk/wealth-manager/the-fsa-fines-which-rocked-financial-services-in-201 http://www.bbc.co.uk/news/business-20492017 http://www.justice.gov/opa/pr/2012/July/12-civ-842.html http://www.nytimes.com/2011/11/04/business/glaxo-to-pay-3-billio http://www.nytimes.com/2011/01/18/busin http://www.justice.gov/opa/pr/2012/May/12-civ-585.html http://www.getfilings.com/comp/k0000001800.html http://www.abbott.com/static/content/micr http://uk.reuters.com/article/2012/12/18/us-amgen-fine-idUSBRE8BH0V620121218 http://www.nytimes.com/2012/12/19/business/amgen-agrees-to-p http://www.justice.gov/opa/pr/2012/October/12-civ-1291.html http://annualreport.boehringer-ingelheim.com/fileadmin/PDF/2012 http://www.bloomberg.com/news/2012-10 http://www.independent.co.uk/news/uk/home-news/pressure-mounts-on-lloyds-boss-as-b http://www.guardian.co.uk/money/2011/may/25/bank-of-scotlandhttp://www.guardian.co.uk/environment/2010/jun/14/gulf-oil-spill-34bn-fines http://www.bp.com/extendedsectiongenericarticle.do?categoryId= http://www.bp.com/extendedsectiongener http://www.justice.gov/opa/pr/2010/April/10-civ-487.html http://www.astrazeneca.com/Investors/financial-information/Finan http://www.astrazeneca.com/cs/Satellite? http://www.getnicklaw.com/media/gsk_media_popup.html http://www.cbsnews.com/2100-18560_162-7195247.html http://www.bloomberg.com/apps/news?pid=newsarchive&sid=a5SIJHgE3rXA http://finance.yahoo.com/q/is?s=hal+Income+Statement&annual http://ir.halliburton.com/phoenix.zhtml?c= http://www.guardian.co.uk/business/2009/mar/01/swiss-banks-anonymity-ubs http://www.ubs.com/global/en/about_ubs/investor_relations/annu http://afp.google.com/article/ALeqM5jTfw http://www.msnbc.msn.com/id/28677805/ns/health-health_care/t/eli-lilly-settles-zyprexa-l http://investor.lilly.com/sec.cfm?SortOrder=Type%20Ascending& http://www.guardian.co.uk/business/2009/sep/02/pfizer-drugs-us-criminal-fine http://www.pfizer.com/investors/financial_reports/financial_report http://www.guardian.co.uk/business/2009 http://news.bbc.co.uk/1/hi/business/8047546.stm http://www.intc.com/intelAR2009/introduction/financial/ http://www.intc.com/results.cfm http://www.nowpublic.com/environment/exxon-valdez-oil-spill-settlement-exxon-pay-507-5 http://www.nytimes.com/1990/01/25/business/company-earnings http://thomson.mobular.net/thomson/7/29 http://www.washingtonpost.com/wp-dyn/content/article/2008/12/15/AR2008121502926.h http://www.siemens.com/annual/08/en/financial_information.htm http://www.siemens.com/investor/pool/en http://www.nytimes.com/2011/11/23/business/merck-agrees-to-pay-950-million-in-vioxx-c http://www.merck.com/investors/financials/annual-reports/home.h http://articles.latimes.com/2006/may/16/business/fi-boeing16 http://www.justice.gov/opa/pr/2006/June/06_civ_412.html http://boeing.com/companyoffices/financi http://business.timesonline.co.uk/tol/business/markets/africa/article734579.ece http://www.shell.com/home/content/investor/financial_information http://www.guardian.co.uk/world/2006/feb http://www.nytimes.com/2006/02/06/business/06insure.html http://www.aigcorporate.com/investors/financial_reports.html#05 http://www.sec.gov/news/press/2006-19.h http://www.endgame.org/corpfines3.html http://www.washingtonpost.com/wp-dyn/content/article/2006/08/2 http://www3.prudential.com/annualreport/ http://www.nytimes.com/2005/02/09/business/worldbusiness/09iht-boa.html http://investor.bankofamerica.com/phoenix.zhtml?c=71595&p=iro http://www.nytimes.com/2005/08/04/business/media/04place.html http://www.getfilings.com/o0000930661-01-000789.html http://www.getfilings.com/o0000950144-0 http://www.endgame.org/corpfines3.html http://www.redorbit.com/news/health/331815/serono_labs_pleads http://www.prnewswire.com/news-release http://www.endgame.org/corpfines1.html http://en.wikipedia.org/wiki/Ahold#History http://money.cnn.com/magazines/fortune http://www.endgame.org/corpfines3.html http://www.scribd.com/doc/269317/Samsung-Annual-Report-200 http://www.justice.gov/atr/public/press_re

http://www.4-traders.com/ROYAL-BANK-OF-SCOTLAND-GR-10759239/financials/ crosoft_(MSFT)/Data/Net_Income .searcymasstort.com/blog/2012/04/06/antipsychotic-drugs-overused-heart-attack-risk-for-elderly-patients/ http://group.barclays.com/about-barclays/investor-relations/financial-results-and-publications/annual-reports http://uk.reuters.com/article/2012/12/11/us-hsbc-probe-idUSBRE8BA05M20121211 http://www.guardian.co.uk/business/2012/dec/14/hsbc-money-laundering-fine-management http://www.guardian.co.uk/business/2012/jul/11/hsbc-failure-control-money-laundering .4-traders.com/STANDARD-CHARTERED-PLC-4003394/financials/ 12/19/uk-ubs-libor-idUKBRE8BI00L20121219 http://www.bbc.co.uk/skillswise/learners/rip-off-britain/rip-off-britain-ppi ss-20492017 http://www.gsk.com/investors/reps11/GSK-Annual-Report-2011.pdf http://www.gsk.com/investors/reps04/annual-report-2004.pdf http://www.gsk.com/investors/reps02/annual-report-2002.pdf http://www.gsk.com/investors/reps00/annual-report-2000.pdf .abbott.com/static/content/microsite/annual_report/2011/01_earnings_statement.php 19/business/amgen-agrees-to-pay-762-million-in-drug-case.html .bloomberg.com/news/2012-10-25/boehringer-to-pay-95-million-to-resolve-drug-promotion-case-1-.html 2011/may/25/bank-of-scotland-fined-complaints-handling .bp.com/extendedsectiongenericarticle.do?categoryId=9039692&contentId=7072683 .astrazeneca.com/cs/Satellite?blobcol=urldata&blobheader=application%2Fpdf&blobheadername1=Content-Disposition&blobheadername2=MDT-Type&b 560_162-7195247.html http://www.getfilings.com/comp/k0000045012.html http://www.ubs.com/global/en/about_ubs/media/emea/annualreporting/archive.html ortOrder=Type%20Ascending&DocType=&DocTypeExclude=&Year= http://www.nytimes.com/2009/09/03/business/03health.html?_r=1 .intc.com/results.cfm mson.mobular.net/thomson/7/2946/4183/ http://www.siemens.com/annual/07/pool/download/pdf/e07_00_gb2007.pdf http://www.siemens.com/investor/pool/en/investor_relations/financial_publications/annual_reports/E04_00_GB2004_ http://www.siemens.com/investor/pool/en/investor_relations/financial_publications/annual_rep http://web.lib.hse.fi/FI/yrityspalvelin/pdf/1996/esiemens.pdf nancials/annual-reports/home.html http://www.boeing.com/companyoffices/financial/finreports/annual/03annualreport/op_hilights.html http://www.boeing.com/companyoffices/financial/finreports/annual/06annualreport/assets/Boeing_06AR_00.pdf http://www.shell.com/home/content/investor/financial_information/annual_reports_and_publications/archive/2006/ .sec.gov/news/press/2006-19.htm http://www3.prudential.com/annualreport/report2004/2004/annual/Annual_Report.pdf /phoenix.zhtml?c=71595&p=irol-reportsannual .getfilings.com/o0000950144-02-011682.html#009 http://www.prnewswire.com/news-releases/serono-and-pfizer-to-co-promote-multiple-sclerosis-treatment-rebifr-in-the-united-states-76134692 http://www.prnewswire.co.uk/news-releases/serono-reports-strong-growth-in-q1-2001-154060565.html http://www2.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/01-10-2001/0 http://www.evaluatepharma.com/Universal/View.aspx?type=Story&id= https://www.ahold.com/Financial-information/Annual-reports/Annual-Report-2002.htm#!/Financial-information/Annual-reports/Annual-Reporthttp://www.washingtonpost.com/wp-dyn/content/article/2005/11/28/AR2005112800144.html https://www.ahold.com/#!/Financial-information/Annual-reports.htm http://www.samsung.com/us/aboutsamsung/ir/financialinformation/annualreport/downloads/2002/eng_Financial_Overview2002.pdf http://www.samsung.com/us/aboutsamsung/ir/financialinformation/annualreport/downloads/2000/eng_digital_e_comp

publications/annual-reports ss/2012/jul/11/hsbc-failure-control-money-laundering

http://www.wikinvest.com/stock/GlaxoSmithKline_(GSK)/Data/Revenue/1998 http://www.wikinvest.com/stock/GlaxoSmithKline_(GSK)/Data/Net_Margin/1998

me1=Content-Disposition&blobheadername2=MDT-Type&blobheadervalue1=inline%3B+filename%3DFigures.pdf&blobheadervalue2=abinary%3B+chars

http://www.siemens.com/investor/pool/en/investor_relations/downloadcenter/gb1998_d_1365091.pdf

s/annual/06annualreport/assets/Boeing_06AR_00.pdf _and_publications/archive/2006/

http://www.thefreelibrary.com/Ares-Serono+Sales+Increase+by+6.3%25+to+US$+918+Million+in+1998.-a053591191 http://www.multsclerosis.org/news/Jan1999/YahooAr al-information/Annual-reports.htm ormation/annualreport/downloads/2000/eng_digital_e_company.pdf

(GSK)/Data/Net_Margin/1998

eadervalue2=abinary%3B+charset%3DUTF-8&blobkey=id&blobtable=MungoBlobs&blobwhere=1285616468942&ssbinary=true

company orange = changed from original graphic HoffmannLa Roche AstraZeneca Bayer Worldcom Boeing Citigroup UBS Schering-Plough Pfizer Wyeth Microsoft QWest Bank Of America Time Warner Serono Laboratories Royal Ahold Samsung Boeing Shell A.I.G Prudential Financial Merck Exxon Mobil Siemens A.G. Halliburton UBS Eli Lilly & Co Pfizer Intel BP AstraZeneca GlaxoSmithKline Lloyds Banking Group BlackRock Inc Card Protection Plan Coutts and Company Lloyds Banking Group: Bank of Scotland PricewaterhouseCoopers Santander Johnson & Johnson (2012)*

nominal fine $m $m 962 355 257 750 73 2,650 100 346 430 13,600 1,450 650 676 2,400 704 1,100 300 615 1,500 1,600 600 950 507 1,600 579 788 1,420 2,300 1,450 34,000 520 750 5 15 16 13 6 2 2 2,200

inflationadjusted year based on (of US CPI, 1999 1344.1 2003 449.1 2003 324.62 2003 948.8 2004 89.34 2004 3265.48 2004 123.23 2004 425.74 2004 529.87 2004 16758.67 2004 1786.77 2004 800.97 2005 805.71 2005 2860.5 2005 839.08 2005 1311.06 2005 357.56 2006 710.1 2006 1731.94 2006 1847.4 2006 692.78 2007 1066.52 2008 548.14 2008 1729.83 2009 628.22 2009 854.98 2009 1540.7 2009 2495.5 2009 1573.25 2010 36294.72 2010 555.1 2010 800.62 2011 5.53 2012 14.72 2012 16.27 2012 13.56 2012 6.51 2012 2.17 2012 2.32 2012 2230.46

Barclays

450

2012 456.23

HSBC Standard Chartered

1,920 634

2012 1946.58 2012 643.07

UBS

1,500

2012 1520.77

HSBC UBS GlaxoSmithKline

2,300 45 3,000

2012 2331.85 2012 46.02 2012 3041.54

Abbott Laboratories Amgen Boehringer Ingelheim

1,500 762 95

2012 1520.77 2012 772.55 2012 96.32

Lloyds Banking Group

2013 7

Sony RBS

0.4 612

2013 0.4 2013 612

United Parcel Service Microsoft

40 731

2013 40 2013 731

Google

2013 7

detail graphic here: http://www.informationisbeautiful.net/2012/punytivedamages-biggest-corporate-fines/ Price fixing on vitamins. Fraud and Inducement - violated the Prescription Drug Marketing Act by providing free samples of cancer) to as Sold drugs to other companies atZoladex a lower (prostate price than what they were charging the US government's Medicaid insurance program, $11bn worth of accounting 'errors'. Discrimination - alleging racial, ethnic and gender discrimination against employees and job applicants. fraud, deceptive trading (multiple fines) Fraud and money laundering. Kickbacks & fraudulent pricing of allergy drug Claritin. Paying $1.8m to an HMO, kickbacks an organization that provides orpromote arranges Provided financial to doctors in order to epilepsyfor drug Neurontin. Liability diet drug fen-phen, which damaged user's hearts.

net income (year of fine $M 4,750 3,036 1,100 -4,222 2,572 17,046 7,080 -950 11,400 1,230 Antitrust - Abusing its dominant market position 8,168 Fraud - inflated sales revenues -1,794 Allowed a select group of traders to make 'improper trades', 16,465 including after the 4pm market close. Deceivingtrading investors about the details of a merger with AOL. 1,253 Fraud & kickbacks - illegal marketing of AIDS wasting drug 570 Serostim and illegal remuneration/incentives paid to doctors to Accounting fraud 293 International price fixing for the computer part, DRAM (dynamic 9,400 random access memory). Contracting scandals. Illegally hiring a senior Air Force official to 2,215 win contracts and to have improperly Damage to land infound the Niger Delta, Nigeria. acquired sensitive 26,300 Improper accounting, bid-rigging and skipped payments to state 14,048 workers' compensation funds.Prudential Financial is not associated 3,430 Deceptive trading (US based with UKacorporation plc) users to suffer heart Selling drug 'Vioxx'Prudential causing some 3,280 attacks/ischemic Exxon Valdez Oil strokes. Spill off coast of Alaska. Punitive damages 45,220 reduced after appeal, see notes. For paying "kickbacks and bribes to win contracts from Iraq's 8,182 government in the United Nations oil-for-food program and for Bribing officials in Nigeria. 1,145 Sham accounts, destroying documents, tax evasion. 2,224 Illegally marketing an anti-psychotic drug (zyprexa) for uses not 4,330 approved by the painkiller FDA. Misbranding Bextra, promoting it for unsuitable uses 8,640 Paying manufacturers to favour its products over those of rivals. 4,400 Gulf of Mexico oil spill -3,324 Illegally marketed the anti-psychotic drug Seroquel for uses not 8,110 approved as safe effective by the drug US Food and Drug Manufactured andand sold contaminated products to Medicaid 5,466 and other government plans. Mishandled complaintshealth by wrongly rejecting 45% of grievances -4,249 relating to its retail investment products. Investment Management arm failed to protect client money such as 2012 not failing to insurance put trust letters in place and failing to control its affairs released Mis-sold products 21 Failed to establish effective anti-money laundering systems and 2012 not controls to high risk customers. released Failed torelating keep accurate records of the mortgage payments of -2,176 250,000 Halifax customers Wrongly told local regulators for seven years that JPMorgan 1,108 Securities was keeping client money safe. on some of its Failed to clarify a compensation procedure 2,865 products. Illegally marketed and failed to warn of side effects for 9,672 antipsychotic drugs Risperdal & Invega and Natrecor, unlisted side effects for elderly Risperdal users found to include seizures, major weight gain, onset of diabetes and potentially fatal high blood sugar. Libor rigging: traders found to be illegally altering interest rates to 9,124 generate profits for the bank and to appear more financially sound than they were. Helped Mexican drug barons launder money through the financial 13,454 system. Hid $250bn worth of transactions that left the financial system 4,786 vulnerable to "terrorists" and "drug kingpins" in the six years up to 2007.

fine as % of company years of crime net income sector year of fine dates 20.25% pharma 1990 - 1999 11.69% pharma 1993-1996 23.33% pharma 1995-2001 -17.76% telecoms 1999 - 2002 2.82% defence 1997-2000 15.55% finance 2000-2001 1.41% finance 1996 - 2003 -36.37% pharma 1998 3.77% pharma 1996-2004 1105.69% pharma 1994 - 1997 17.75% tech 1993 -36.23% telecoms 1999-2001 4.11% finance 1998 - 2003 191.54% media 1999 - 2002 123.51% pharma 1997-2001 375.43% retail 2001-2002 3.19% tech 1999-2002 27.77% defence 1998-2003 5.70% energy 2000 11.39% finance 1991 - 2004 17.49% finance 2001-2003 28.96% pharma 2004 1.12% energy 1989 19.56% tech 1995-2007 50.57% defence 1994 - 2004 35.43% finance 2001 - 2006 32.79% pharma 1999-2001 26.62% pharma 2001 - 2005 32.95% tech 2002 - 2007 -1022.86% energy 2010 6.41% pharma 2001-2006 13.72% pharma 2001 - 2005 -0.13% finance 2007 - 2009 http://www2.b finance 2006 - 2010 lackrock.com/ 75.18% finance 2005 - 2011 http://international.coutts.com/files/pdfs/Reports-and-publi finance 2007 - 2010 -0.30% finance 2004 - 2011 0.19% finance 2002 - 2009 0.08% finance 2008 - 2010 22.75% pharma 1998 - 2003

4.93%

finance

2005 - 2009

14.27% 13.25%

finance finance

2004 - 2010 2001 - 2007

Libor rigging: traders found to be illegally altering interest rates to -2,658 generate profits for the bank and to appear more financially sound than they were. Mis-sold payment protection insurance. 13,454 After Kweku Adoboli caused 'substantial losses' totaling US$2.3 billion. Medicaid fraud, illegal sales practices related to nine drugs, and also product liability cases over its marketing of the diabetes drug Avandia. GSK paid doctors and manipulated medical research to promote the drug. Promoted the anti-seizure drug Depakote for uses unapproved by the U.S. Food and Drug Administration. Illegally introduced and promoted several drugs including Aranesp, a drug to treat anemia. Promoted several drugs for non- medically accepted uses -2,658 8,182

-56.44%

finance

2005 - 2010

17.10% -1.71% 36.66%

finance finance pharma

2001 - 2011 2006 - 2011 1994-2007

4,728 4,345 1,237

31.73% 17.54% 7.68%

pharma pharma pharma

1998-2006 since 2007 no data

For delayed compensation payments to up to 140,000 customers who were mis-sold payment protection insurance.

-2,176

-0.30%

finance

2011 - 2012

Leaked personal details of millions of gamers online including 130 passwords and credit card numbers. Libor rigging: traders found to be illegally altering interest rates to -5,971 generate profits for the bank and to appear more financially sound than they were. Failed to stop fake online pharmacies from using their service 807 Failed to offer users a choice of web browser. This is an unprecedented sanction that will act as a warning to other firms. 15,460

0.29% -10.25%

tech finance

2011 2006 - 2010

4.96% 4.73%

other tech

since 2003 2011 - 2012

Collected people's personal data without authorisation as part of its 9,737 Street View service.

0.07%

tech

2008 - 2010

years of crime crime category duration, : corruption (inc. years fraud & mis-selling) 9 corruption: fraud 3 corruption: fraud 6 corruption: fraud 3 error 3 discrimination 1 corruption: fraud 7 corruption: fraud 0 corruption: fraud 8 corruption: misselling 3 corruption: misselling 0 anti-competitive 2 5 3 4 1 3 5 0 13 2 0 0 12 10 5 2 4 5 0 5 4 5 corruption: fraud corruption corruption: fraud corruption: misselling corruption: fraud corruption: fraud corruption error corruption: fraud corruption: fraud corruption: misselling error corruption corruption corruption: fraud corruption: misselling corruption: misselling corruption error corruption: misselling error corruption: misselling

time delay: years from 9 10 8 4 7 4 8 6 8 10 11 5 7 6 8 4 6 8 6 15 5 3 19 13 15 10 10 8 7 0 9 9 14

time delay: years from 0 7 2 1 4 3 1 6 0 7 11 3 2 3 4 3 3 3 6 2 3 3 19 1 5 3 8 4 2 0 4 5 9

net income (year as onof 4- fine) traders -3,324 8,053 1,634 -4,249 21 -2,176 2,865 10,853

operating profit as on (year 4traders 31,740 13,603 9,129 no data 52 12,661 30,610 20,308

operating income as on 4traders 42,904 15,258 11,200 no data 69 7,216 33,454 23,974

link http://www.4-traders.com/BP-PL http://www.4-traders.com/ASTR http://www.4-traders.com/GLAX http://www.4-traders.com/LLOYD http://www.4-traders.com/CPPG http://www.4-traders.com/LLOYD http://www.4-traders.com/BANC http://www.4-traders.com/JOHN

corruption: fraud

-1,590

10,549 12,234

http://www.4-traders.com/BARC

6 6

corruption: fraud corruption: fraud

8 11

2 5

13,454 4,786

25,403 27,934 8,785 9,453

http://www.4-traders.com/HSBC

http://www.4-traders.com/STAN

corruption: fraud

-2,658

3,318 4,047

http://www.4-traders.com/UBS-A

10 5 13

corruption: misselling error corruption

11 6 18

1 1 5

13,454 -2,658 4,565

25,403 27,934 3,318 4,047 8,330 9,415

http://www.4-traders.com/HSBC

http://www.4-traders.com/UBS-A

http://www.4-traders.com/GLAX

8 -

corruption: misselling corruption: misselling corruption: misselling -

14 5 -

6 -

5,963 4,345 -

9,833 12,616 6,517 7,605 -

http://www.4-traders.com/ABBO

http://www.4-traders.com/AMGE -

-2,176

12,661 7,216

http://www.4-traders.com/LLOYD

corruption: fraud

-4,589 -5,971

(601) no data 11,168 12,792

http://www.4-traders.com/SONY

http://www.4-traders.com/ROYA

error anti-competitive

807 16,978

7,070 8,928 27,956 30,923

http://www.4-traders.com/UNITE

http://www.4-traders.com/MICRO

error

10,737

15,967 18,929

http://www.4-traders.com/GOOG

fine $bn US Department of 500 million in US, 462 in Europe. 0.96 Justice and EU Department of Net income = "Net profit for the year" 0.36 Health DOJ and Cross referenced DEM exchange rates with EURO on multiple 0.26 Annual Reports to ensure 1995-1997 were correct for YoC. 0.75 Securities and Filed for bankruptcy in 2002 following #'s discrepancies with Exchange accounting. Years fine profits is last recorded from 2002. U.S. District Court Net income = "Net of Earnings" 0.07 in Seattle New York state multiple fines 2.65 Federal Reserve 0.10 DOJ, Eastern (now merck) 0.35 District of US Jury 0.43 Mass litigation, "reports state that over all, Wyeth has paid $13.6 billion to 13.60 multiple suits. settle fen-phen claims" Years of crime relate to year when European 497m euros in 2004 1.45 Commission for antiSEC 0.65 Securities and 0.68 Exchange Minnesota State 2001 + 2002 revenues as AOL Time Warner 2.40 Board of DOJ, District of (now merck) 0.70 Massachusetts SEC & Dutch Law 1.10 Enforcement DOJ 0.30 U.S. Departments 0.62 of Justice, State, Nigerian National 1.50 Assembly SEC 1.60 SEC 2006 - consolidated net income 0.60 Separate federal Years of crimes 2004. 0.95 and state Court lawsuits Punitive damages reduced from $5 billion to only $507.5 Supreme 0.51 million after appeals that took place nearly 20 years after spill. US & German 1.60 courts SEC 0.58 US Investigators 0.79 Office of Consumer 1.42 Litigation of the of US Department 2.30 Justice European 1.06bn euros, 948m 1.45 Commission for anti- Original net income figure (30,676) changed by Ella, 2013 Various to cover 34.00 compensation DOJ and Health 0.52 and Human Civil settlement 0.75 http://www.4-traders.com/LLOYDS-BANKING-GROUP-PLC-4000786/financials/ FSA FSA FSA FSA FSA Net income = total profit for the financial year FSA http://www.4-traders.com/JOHNSON-JOHNSON-4832/financials/ J&J has agreed to up to $2.2 billion ($600m criminal penalty) 2.20 amounts to less than 10 percent of the Risperdal sales or $24 billion since 2003. antipsychotic drug industry totalled about $16 billion in sales in 2010. 2011 financials used for year of fine. FSA Used 2011 for years of fine financials 0.45

fined by

notes

revenue (years of $bn 26.03 18.85 35.11 32.20 53.62 79.64 35.96 8.27 52.40 17.36 36.84 13.81 56.09 8.81 2.59 56.94 140.90 61.53 318.85 113.19 24.85 24.20 459.58 107.64 14.68 23.66 21.84 50.01 35.10 308.93 33.27 41.04

net income (years of $bn 4.75 3.04 -1.67 -4.22 2.57 17.05 7.08 -0.95 11.40 1.23 8.17 -1.79 16.47 1.25 0.57 0.29 9.40 2.22 26.30 14.05 3.43 3.28 45.22 8.18 1.15 2.22 4.33 8.64 4.40 30.68 8.11 5.47

65.00

9.67

50.12

9.12

http://www.4-traders.com/HSBC-HOLDINGS-PLC-4001224/financials/ US regulators for breaking US sanctions on Iran & other countries

US, UK and Swiss regulators http://www.4-traders.com/HSBC-HOLDINGS-PLC-4001224/financials/ FSA Mass litigation, Used 2011 for years of fine financials multiple suits. DOJ 3.00 42.60 8.18

US Justice Used 2011 for years of fine financials Department http://www.4-traders.com/AMGEN-INC-4847/financials/

1.50 38.85

4.73

FSA

ICO http://www.4-traders.com/ROYAL-BANK-OF-SCOTLAND-GR-10759239/financials/

http://www.4-traders.com/UNITED-PARCEL-SERVICE-IN-14758/financials/ EU

US

revenue (years $bn ? of 102.18 26.87 352.72 146.33 211.63 223.85 148.70 8.08 262.98 50.63 215.02 49.49 206.87 22.93 5.46 110.67 105.72 274.15 191.51 583.82 53.82 7.97 96.08 1,034.02 135.82 209.99 32.41 203.60 308.93 124.76 173.87

net income (years $bn ? of 19.01 4.36 19.48 -72.63 6.19 27.65 36.10 1.76 51.43 7.13 59.30 -2.76 49.44 -18.33 0.97 -0.44 15.62 9.10 12.72 59.87 1.30 0.42 3.81 38.12 0.37 43.53 8.56 38.25 30.68 23.38 37.48

Chief sources Inflation adjustment: BLS Inflation Accutaneaction, Roche New York Times, Edgar-Online, New York Times, Bayer, Wiley Guardian, BBC, Get Filings Boeing, Komonews LA Times, Citigroup New York Times, UBS Department of Justice, Washington Post, New York Times, Pfizer, Buck New York Times, Corporate IR BBC, Microsoft Washington Post, Porticus, New YorkMorning Times, Star Bank of America New York Times, Get Filings Red Orbit, PRNewsWire, CNN, Ahold Department of Justice, Scribd, Samsung Endgame, Boeing Guardian, The Times, Shell York Times, AIG, New Securities Exchange Washington Post, Prudential Boston Herald, Merck NowPublic, New York Times, Thomson Washington Post, Siemens Bloomberg, Halliburton, Getfilings Guardian, UBS MSNBC, Lilly Investor Relations Guardian, New York Times, Pfizer BBC, Intel Guardian, BP Department of Justice, AstraZeneca CBS News, Get Nick Law Independent; Guardian City Wire; BBC News City Wire; Insurance Daily City Wire; Coutts City Wire; Lloyds Banking Group; BBC City Wire; Reuters; PwC City Wire; Reuters

191.04

32.13

Bloomberg, Reuters

Source Links http://www.bls.gov/data/inflation_calculator.htm http://www.accutaneaction.com/Frauds/roche_finc_frauds.html http://webcache.googleusercontent.com/search?q=cache:NQzeV http://www.roche.com/gb99e.pdf http://www.nytimes.com/2003/06/21/business/21CANC.html http://google.brand.edgar-online.com/EFX_dll/EDGARpro.dll?Fet http://www.astrazeneca.com/Investors/fin http://www.quitamhelp.com/static/stories/bayer-glaxo.html http://www.nytimes.com/2003/04/17/business/17DRUG.html?pag http://www.bayer.com/en/en-ar-complete. http://news.bbc.co.uk/1/hi/business/3053068.stm http://www.guardian.co.uk/business/2002/aug/09/corporatefraud. http://www.getfilings.com/o0001193125-0 http://www.endgame.org/corpfines1.html http://www.boeing.com/companyoffices/financial/finreports/annua http://www.komonews.com/news/archive/ http://www.citigroup.com/citi/investor/sec.htm http://articles.latimes.com/2004/may/11/business/fi-citi11 http://www.endgame.org/corpfines4.html http://www.nytimes.com/2004/05/11/business/ubs-fined-100-millio http://www.ubs.com/global/en/about_ubs/ http://www.endgame.org/corpfines3.html http://www.quitamhelp.com/static/stories/schering.html http://www.justice.gov/opa/pr/2004/July/0 http://www.nytimes.com/2004/05/14/business/pfizer-to-pay-430-million-over-promoting-dr http://www.pfizer.com/investors/financial_reports/financial_report http://buck.com/annual_report?idx=P&co= http://www.endgame.org/corpfines4.html http://www.nytimes.com/2005/02/12/business/12law.html?scp=11 http://library.corporate-ir.net/library/78/78 http://news.bbc.co.uk/1/hi/business/8047546.stm http://www.microsoft.com/msft/ar04/nonflash/10k_dl_main.html http://www.endgame.org/corpfines3.html http://www.washingtonpost.com/wp-dyn/articles/A53148-2004Oct http://en.wikipedia.org/wiki/Accounting_sc http://www.nytimes.com/2005/02/09/business/worldbusiness/09iht-boa.html http://investor.bankofamerica.com/phoenix.zhtml?c=71595&p=iro http://www.nytimes.com/2005/08/04/business/media/04place.html http://www.getfilings.com/o0000930661-01-000789.html http://www.getfilings.com/o0000950144-0 http://www.endgame.org/corpfines3.html http://www.redorbit.com/news/health/331815/serono_labs_pleads http://www.prnewswire.com/news-release http://www.endgame.org/corpfines1.html http://en.wikipedia.org/wiki/Ahold#History http://money.cnn.com/magazines/fortune http://www.endgame.org/corpfines3.html http://www.scribd.com/doc/269317/Samsung-Annual-Report-200 http://www.justice.gov/atr/public/press_re http://articles.latimes.com/2006/may/16/business/fi-boeing16 http://www.justice.gov/opa/pr/2006/June/06_civ_412.html http://boeing.com/companyoffices/financi http://business.timesonline.co.uk/tol/business/markets/africa/article734579.ece http://www.shell.com/home/content/investor/financial_information http://www.guardian.co.uk/world/2006/feb http://www.nytimes.com/2006/02/06/business/06insure.html http://www.aigcorporate.com/investors/financial_reports.html#05 http://www.sec.gov/news/press/2006-19.h http://www.endgame.org/corpfines3.html http://www.washingtonpost.com/wp-dyn/content/article/2006/08/2 http://www3.prudential.com/annualreport/ http://www.nytimes.com/2011/11/23/business/merck-agrees-to-pay-950-million-in-vioxx-c http://www.merck.com/investors/financials/annual-reports/home.h http://www.nowpublic.com/environment/exxon-valdez-oil-spill-settlement-exxon-pay-507-5 http://www.nytimes.com/1990/01/25/business/company-earnings http://thomson.mobular.net/thomson/7/29 http://www.washingtonpost.com/wp-dyn/content/article/2008/12/15/AR2008121502926.h http://www.siemens.com/annual/08/en/financial_information.htm http://www.siemens.com/investor/pool/en http://www.bloomberg.com/apps/news?pid=newsarchive&sid=a5SIJHgE3rXA http://finance.yahoo.com/q/is?s=hal+Income+Statement&annual http://ir.halliburton.com/phoenix.zhtml?c= http://www.guardian.co.uk/business/2009/mar/01/swiss-banks-anonymity-ubs http://www.ubs.com/global/en/about_ubs/investor_relations/annu http://afp.google.com/article/ALeqM5jTfw http://www.msnbc.msn.com/id/28677805/ns/health-health_care/t/eli-lilly-settles-zyprexa-l http://investor.lilly.com/sec.cfm?SortOrder=Type%20Ascending& http://www.guardian.co.uk/business/2009/sep/02/pfizer-drugs-us-criminal-fine http://www.pfizer.com/investors/financial_reports/financial_report http://www.guardian.co.uk/business/2009 http://news.bbc.co.uk/1/hi/business/8047546.stm http://www.intc.com/intelAR2009/introduction/financial/ http://www.intc.com/results.cfm http://www.guardian.co.uk/environment/2010/jun/14/gulf-oil-spill-34bn-fines http://www.bp.com/extendedsectiongenericarticle.do?categoryId= http://www.bp.com/extendedsectiongener http://www.justice.gov/opa/pr/2010/April/10-civ-487.html http://www.astrazeneca.com/Investors/financial-information/Finan http://www.astrazeneca.com/cs/Satellite? http://www.getnicklaw.com/media/gsk_media_popup.html http://www.cbsnews.com/2100-18560_162-7195247.html http://www.independent.co.uk/news/uk/home-news/pressure-mounts-on-lloyds-boss-as-b http://www.guardian.co.uk/money/2011/may/25/bank-of-scotlandhttp://citywire.co.uk/wealth-manager/the-fsa-fines-which-rocked-financial-services-in-201 http://www.bbc.co.uk/news/business-19559439 http://citywire.co.uk/wealth-manager/the-fsa-fines-which-rocked-financial-services-in-201 http://www.insurancedaily.co.uk/2012/11/15/fsa-fines-card-protec http://citywire.co.uk/wealth-manager/the-fsa-fines-which-rocked-financial-services-in-201 http://www.coutts.com/news-and-insights/press-releases/2012/co http://citywire.co.uk/wealth-manager/the-fsa-fines-which-rocked-financial-services-in-201 http://www.lloydsbankinggroup.com/media/pdfs/investors/2013/20 http://www.bbc.co.uk/news/business-1999 http://citywire.co.uk/wealth-manager/the-fsa-fines-which-rocked-financial-services-in-201 http://www.reuters.com/article/2012/01/06/accounting-pwc-fine-id http://www.pwc.co.uk/annualreport/our-pe http://citywire.co.uk/wealth-manager/the-fsa-fines-which-rocked-financial-services-in-201 http://uk.reuters.com/article/2012/02/20/uk-santander-fsa-idUKTR http://www.bloomberg.com/news/2012-06-11/j-j-said-to-pay-2-2-billion-to-end-risperdal-sa http://www.reuters.com/article/2012/06/08/johnsonandjohnson-ris http://www.searcymasstort.com/blog/2012

201.25

164.40

Guardian

2012

http://www.guardian.co.uk/business/2012/jun/27/barclays-chief-b http://www.guardian.co.uk/business/2012

Guardian; HSBC; 4traders; Reuters Guardian; Standard Chartered; 4-Traders

http://www.guardian.co.uk/business/2013/mar/04/hsbc-pay-top-earners http://www.hsbc.com/financialresults http://www.4-traders.com/HSBC-HOLDIN

http://www.guardian.co.uk/business/2013/mar/28/standardchartered-executive-pay-bonu http://reports.standardchartered.com/annual-report-2012/financia http://www.4-traders.com/STANDARD-CH

City Wire; Reuters

http://citywire.co.uk/wealth-manager/the-fsa-fines-which-rocked-financial-services-in-201 http://uk.reuters.com/article/2012/12/19/uk-ubs-libor-idUKBRE8B

Guardian; HSBC; 4traders; BBC City Wire; BBC News 377.27 93.77

http://www.guardian.co.uk/business/2013/mar/04/hsbc-pay-top-earners http://www.hsbc.com/financialresults http://www.4-traders.com/HSBC-HOLDIN

http://citywire.co.uk/wealth-manager/the-fsa-fines-which-rocked-financial-services-in-201 http://www.bbc.co.uk/news/business-20492017

New York Times, GSK http://www.justice.gov/opa/pr/2012/July/12-civ-842.html http://www.nytimes.com/2011/11/04/business/glaxo-to-pay-3-billio http://www.nytimes.com/2011/01/18/busin

150.40

22.98

Department of Justice, http://www.justice.gov/opa/pr/2012/May/12-civ-585.html http://www.getfilings.com/comp/k0000001800.html http://www.abbott.com/static/content/micr Get Filings Reuters; NY Times http://uk.reuters.com/article/2012/12/18/us-amgen-fine-idUSBRE8BH0V620121218 http://www.nytimes.com/2012/12/19/business/amgen-agrees-to-p

US gov; Boehringer http://www.justice.gov/opa/pr/2012/October/12-civ-1291.html http://annualreport.boehringer-ingelheim.com/fileadmin/PDF/2012 http://www.bloomberg.com/news/2012-10 Ingelheim; Bloomberg

Guardian; Lloyds http://www.guardian.co.uk/money/2013/feb/19/payment-protection-insurance-insurance http://www.lloydsbankinggroup.com/media/pdfs/investors/2012/20 http://www.4-traders.com/LLOYDS-BANK Banking Group; 4traders Guardian; Sony; http://www.guardian.co.uk/technology/2013/jan/24/sony-fined-over-playstation-hack http://www.sony.net/SonyInfo/IR/financial/ar/2012/common/docs/ https://www.google.co.uk/search?q=yen+ Currency converter BBC News; Guardian; http://www.bbc.co.uk/news/business-21356256 http://www.guardian.co.uk/business/2013/feb/06/royal-bank-of-sc http://www.investors.rbs.com/download/a RBS; 4-traders Safe Medicines Reuters; Wiki Invest

http://www.safemedicines.org/2013/04/ups-agrees-to-40-million-fine-in-fake-online-pharm

http://uk.reuters.com/article/2013/03/06/us-eu-microsoft-idUSBRE92500520130306 http://www.wikinvest.com/stock/Microsoft_(MSFT)/Data/Net_Inco

BBC news; Google Investor

http://www.bbc.co.uk/news/technology-21762545 http://investor.google.com/financial/tables.html

.roche.com/gb99e.pdf http://www.astrazeneca.com/cs/Satellite?blobcol=urldata&blobheader=application%2Fpdf&blobheadername1=Content-Disposition&blobhead http://www.wiley.com/college/kieso/0471363049/dt/analysttool/realco/bayer/abschluss_rechnung_en.html http://www.bayer.com/en/en_ar_complete_2004.pdfx .getfilings.com/o0001193125-04-039709.html#tx43272_7 .komonews.com/news/archive/4169196.html ay/11/business/fi-citi11 .ubs.com/global/en/about_ubs/investor_relations/annualreporting/archive.html http://media.corporate-ir.net/media_files/IROL/89/89839/reports/sgp_ar04a.pdf http://www.consumeraffairs.com/news04/claritin.html http://www.contractormisconduct.org/ass/contractors/178/cases/1266/1798/schering-plough-c http://www.washingtonpost.com/wp-dyn/content/article/2006/08/29/AR .com/annual_report?idx=P&co=PFE&yr=97&nam=DEMO&pw=DEMO http://www.nytimes.com/2005/02/17/business/17wyeth.html?scp=2&sq=Wyeth+fen+phen&st=nyt 4/nonflash/10k_dl_main.html http://www.porticus.org/bell/pdf/Qwest_AR2005.pdf http://en.wikipedia.org/wiki/Qwest#Accounting_and_insider_trading_irregularities http://quote.morningstar.com/stock-filing/Annual-Report/2001/12/31/t.aspx?t=XNYS:Q&ft=10/phoenix.zhtml?c=71595&p=irol-reportsannual .getfilings.com/o0000950144-02-011682.html#009 http://www.prnewswire.com/news-releases/serono-and-pfizer-to-co-promote-multiple-sclerosis-treatment-rebifr-in-the-united-states-76134692 http://www.prnewswire.co.uk/news-releases/serono-reports-strong-growth-in-q1-2001-154060565.html http://www2.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/01-10-2001/0 http://www.evaluatepharma.com/Universal/View.aspx?type=Story&id= https://www.ahold.com/Financial-information/Annual-reports/Annual-Report-2002.htm#!/Financial-information/Annual-reports/Annual-Reporthttp://www.washingtonpost.com/wp-dyn/content/article/2005/11/28/AR2005112800144.html https://www.ahold.com/#!/Financial-information/Annual-reports.htm http://www.samsung.com/us/aboutsamsung/ir/financialinformation/annualreport/downloads/2002/eng_Financial_Overview2002.pdf http://www.samsung.com/us/aboutsamsung/ir/financialinformation/annualreport/downloads/2000/eng_digital_e_comp http://www.boeing.com/companyoffices/financial/finreports/annual/03annualreport/op_hilights.html http://www.boeing.com/companyoffices/financial/finreports/annual/06annualreport/assets/Boeing_06AR_00.pdf http://www.shell.com/home/content/investor/financial_information/annual_reports_and_publications/archive/2006/ .sec.gov/news/press/2006-19.htm http://www3.prudential.com/annualreport/report2004/2004/annual/Annual_Report.pdf nancials/annual-reports/home.html mson.mobular.net/thomson/7/2946/4183/ http://www.siemens.com/annual/07/pool/download/pdf/e07_00_gb2007.pdf http://www.siemens.com/investor/pool/en/investor_relations/financial_publications/annual_reports/E04_00_GB2004_ http://www.siemens.com/investor/pool/en/investor_relations/financial_publications/annual_rep http://web.lib.hse.fi/FI/yrityspalvelin/pdf/1996/esiemens.pdf http://www.getfilings.com/comp/k0000045012.html http://www.ubs.com/global/en/about_ubs/media/emea/annualreporting/archive.html ortOrder=Type%20Ascending&DocType=&DocTypeExclude=&Year= http://www.nytimes.com/2009/09/03/business/03health.html?_r=1 .intc.com/results.cfm .bp.com/extendedsectiongenericarticle.do?categoryId=9039692&contentId=7072683 .astrazeneca.com/cs/Satellite?blobcol=urldata&blobheader=application%2Fpdf&blobheadername1=Content-Disposition&blobheadername2=MDT-Type&b 560_162-7195247.html 2011/may/25/bank-of-scotland-fined-complaints-handling ss-19559439 012/11/15/fsa-fines-card-protection-plan-10-5-million/ nsights/press-releases/2012/coutts-financial-services-authority-settlement/ .bbc.co.uk/news/business-19995766 .pwc.co.uk/annualreport/our-performance/financial-performance.jhtml 02/20/uk-santander-fsa-idUKTRE81J0LG20120220 .searcymasstort.com/blog/2012/04/06/antipsychotic-drugs-overused-heart-attack-risk-for-elderly-patients/

http://group.barclays.com/about-barclays/investor-relations/financial-results-and-publications/annual-reports

http://uk.reuters.com/article/2012/12/11/us-hsbc-probe-idUSBRE8BA05M20121211 http://www.guardian.co.uk/business/2012/dec/14/hsbc-money-laundering-fine-management http://www.guardian.co.uk/business/2012/jul/11/hsbc-failure-control-money-laundering

.4-traders.com/STANDARD-CHARTERED-PLC-4003394/financials/

12/19/uk-ubs-libor-idUKBRE8BI00L20121219

http://www.bbc.co.uk/skillswise/learners/rip-off-britain/rip-off-britain-ppi

ss-20492017 http://www.gsk.com/investors/reps11/GSK-Annual-Report-2011.pdf http://www.gsk.com/investors/reps04/annual-report-2004.pdf http://www.gsk.com/investors/reps02/annual-report-2002.pdf http://www.gsk.com/investors/reps00/annual-report-2000.pdf

.abbott.com/static/content/microsite/annual_report/2011/01_earnings_statement.php

19/business/amgen-agrees-to-pay-762-million-in-drug-case.html

.bloomberg.com/news/2012-10-25/boehringer-to-pay-95-million-to-resolve-drug-promotion-case-1-.html

.4-traders.com/LLOYDS-BANKING-GROUP-PLC-4000786/financials/

w.google.co.uk/search?q=yen+to+dollar&aq=0&oq=yen+to+dollar&aqs=chrome.0.0j60j0l2j60j0.1680j0&sourceid=chrome&ie=UTF-8 http://www.4-traders.com/ROYAL-BANK-OF-SCOTLAND-GR-10759239/financials/

million-fine-in-fake-online-pharmacy-case-525.html

crosoft_(MSFT)/Data/Net_Income

n%2Fpdf&blobheadername1=Content-Disposition&blobheadername2=MDT-Type&blobheadervalue1=inline%3B+filename%3D1995---1997.pdf&blobheade

http://buck.com/arimages/?idx=s&co=SGP&pg=003&res=l&yr=04&np=68&nam=DEMO&pw=DEMO

n+phen&st=nyt

k-filing/Annual-Report/2001/12/31/t.aspx?t=XNYS:Q&ft=10-K405&d=c0a6b3539d02e644

http://www.thefreelibrary.com/Ares-Serono+Sales+Increase+by+6.3%25+to+US$+918+Million+in+1998.-a053591191 http://www.multsclerosis.org/news/Jan1999/YahooAr al-information/Annual-reports.htm ormation/annualreport/downloads/2000/eng_digital_e_company.pdf s/annual/06annualreport/assets/Boeing_06AR_00.pdf _and_publications/archive/2006/

http://www.siemens.com/investor/pool/en/investor_relations/downloadcenter/gb1998_d_1365091.pdf

me1=Content-Disposition&blobheadername2=MDT-Type&blobheadervalue1=inline%3B+filename%3DFigures.pdf&blobheadervalue2=abinary%3B+chars

publications/annual-reports

ss/2012/jul/11/hsbc-failure-control-money-laundering

http://www.wikinvest.com/stock/GlaxoSmithKline_(GSK)/Data/Revenue/1998 http://www.wikinvest.com/stock/GlaxoSmithKline_(GSK)/Data/Net_Margin/1998

.1680j0&sourceid=chrome&ie=UTF-8

%3D1995---1997.pdf&blobheadervalue2=abinary%3B+charset%3DUTF-8&blobkey=id&blobtable=MungoBlobs&blobwhere=1285616469787&ssbinary=tru

eadervalue2=abinary%3B+charset%3DUTF-8&blobkey=id&blobtable=MungoBlobs&blobwhere=1285616468942&ssbinary=true

(GSK)/Data/Net_Margin/1998

here=1285616469787&ssbinary=true

can we extract any patterns from the (complete) data we have. trends in fines per industry, delays in fines, by industry energy media pharma retail finance tech telecoms defence other by year 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 1999

excluding # entrie 3 1 17 1 13 6 2 3 1 47 4 11 3 5 2 1 4 5 8 3 1 47

average fine, $m nominal $12,002 $2,400 $1,774 $1,100 $935 $923 $700 $422 $40

average fine, $m inflation $12,858 $2,861 $2,047 $1,311 $1,211 $1,031 $875 $476 $40

average fine as % of income -339% 192% 87% 375% 5% 13% -27% 27% 5%

$348 $1,310 $11,757 $1,307 $369 $950 $1,079 $1,036 $2,412 $454 $962

$348 $1,328 $12,550 $1,419 $1,139 $1,067 $1,246 $1,235 $2,973 $574 $1,344 0.000225 0.04 no trend

most frequent crime category corruption: fraud corruption: mis-selling error corruption anti-competitive discrimination

0% 10% -334% 36% 10% 29% 16% 140% 134% 6% #REF! #REF! #REF! no trend / v v weak negative

18 12 8 6 2 1 47

average duration of crime, years 0 3 5 1 6 4 3 6 -

average time delay: years from 8 6 9 4 8 7 5 10 -

average time delay: years from 8 3 5 3 2 3 2 4 -

most frequent crime category error corruption: mis-selling corruption: fraud corruption corruption -

note inc. BP Gulf oil spill

2 7 3 5 6 0 5 3 3 4 9 -0.503681 0.09 no trend

5 10 6 10 16 3 9 6 7 7 9 -0.032606 0.00 no trend

2 4 3 4 10 3 4 3 4 3 0 0.405705 0.06 no trend

error corruption: mis-selling error corruption / corruption: mis-selling corruption: fraud corruption: fraud corruption: fraud corruption: fraud -

<< BP Gulf oil spill

Net Income 2463.8 1253 620 7500 1500 16465 14000 26300 3072 2200 3300 5886 6697 8600 4400 4300 8100 2619.96 30676 10853 8200 476 5963 4790 2600 15334 15334 10700 4300 16978 9573

SQRT 49.63667999 35.39774004 24.8997992 86.60254038 38.72983346 128.3160161 118.3215957 162.1727474 55.42562584 46.9041576 57.44562647 76.72027112 81.83520025 92.73618495 66.33249581 65.57438524 90 51.18554483 175.1456537 104.1777327 90.55385138 21.81742423 77.22046361 69.20982589 50.99019514 123.8305294 123.8305294 103.4408043 65.57438524 130.2996546 97.8417089 0 0

SQRT / 1.87 26.54367914 18.92927275 13.31540064 46.31151892 20.71114089 68.61819045 63.27358057 86.72339433 29.63937211 25.08243722 30.71958635 41.02688295 43.76213917 49.59154276 35.47192289 35.06651617 48.12834225 27.37194911 93.66077736 55.71001751 48.42451946 11.66707178 41.29436557 37.01060208 27.26748403 66.21953441 66.21953441 55.31593814 35.06651617 69.6789597 52.32176946 0 0

% of Net Income 18 192 114 3 4 12 6 20 28 29 27 12 27 33 33 6 29 111 20.2 37 96 25 13 56 15 13 0.07 18 4 6

SQRT 443.484 2405.76 706.8 225 0 658.6 1680 1578 614.4 616 957 1589.22 803.64 2322 1452 1419 486 759.7884 34050.36 2192.306 3034 456.96 1490.75 622.7 1456 2300.1 1993.42 7.49 774 679.12 574.38 0 0 21.05905981 49.04854738 26.58571045 15 0 25.66320323 40.98780306 39.72404813 24.78709342 24.81934729 30.9354166 39.86502226 28.34854494 48.18713521 38.10511777 37.6696164 22.04540769 27.56425947 184.5273963 46.82206745 55.08175742 21.37662275 38.6102318 24.9539576 38.15756806 47.95935779 44.64773231 2.736786437 27.82085549 26.05993093 23.96622624 0 0

SQRT / 1.87 11.26152931 26.22916972 14.21695746 8.021390374 0 13.72363809 21.91861126 21.24280649 13.25513017 13.27237823 16.54300353 21.31819372 15.1596497 25.7685215 20.37706832 20.1441799 11.78898807 14.7402457 98.67775205 25.03853874 29.45548525 11.43134906 20.64718278 13.34436235 20.40511661 25.6467154 23.87579268 1.463522159 14.87746283 13.93579194 12.81616376 0 0

company
Union Carbide HoffmannLa Roche Wal-Mart AstraZeneca 2 Bayer Flextronics Worldcom Boeing Citigroup UBS Pfizer Schering-Plough Wyeth Microsoft QWest Enron Bank Of America Wellpoint Health Networks Adelphia AOL / Timewarner Time Warner Serono Laboratories Abercrombie & Fitch Royal Ahold Samsung Shell A.I.G Prudential Financial Merck Exxon Mobil Siemens A.G. Halliburton Exxon Mobil UBS Eli Lilly & Co Pfizer Intel Toyota BP BP Shell AstraZeneca

detail
Bhopal Disaster - a list of errors led to a spill of toxic material that killed 3000+ people. Price fixing on vitamins. Employment practices - forced overtime and hired illegal immigrants. Fraud and Inducement - violated the Prescription Drug Marketing Act by providing free samples of cancer) to as Sold drugs to other companies atZoladex a lower (prostate price than what they were charging the of US government's Medicaid insurance program, Fraud and breach contract after pulling out of a contract to supply worth circuitof boards for medical testing devices. $11bn accounting 'errors'.

company

fine $m
470 962 50 355 257 23 750 73 2,650 100 430 346 13,600 497 650 1,700 676 448 715 2,600 2,400 704 50 1,100 300 1,500 1,600 600 4,800 507 1,600 579 105 788 1,420 2,300 1,450 16 5 34,000 48 520

energy pharma retail pharma pharma tech telecoms Discrimination - alleging racial, ethnic and gender discrimination defence against employees and job applicants. fraud, deceptive trading (multiple fines) finance Fraud and money laundering. finance Provided financial kickbacks to doctors in order to promote pharma epilepsy drug Kickbacks & fraudulent pricing of allergy drug Claritin. Paying pharma $1.8m to an HMO, an organization that provides or arranges Liability for diet drug fen-phen, which damaged user's hearts. pharma Antitrust - Abusing its dominant market position tech Fraud - inflated sales revenues telecoms Improper trading in western US electricity markets. energy Allowed a select group of traders to make 'improper trades', finance including trading after thephysicians. 4pm market close. Underpaid hospitals and healthcare Fraud - Rigas Family who owned Adelphia skimmed $2.3 billion in media assets fromaccounting company to pay for their own lifestyle, also misled Fraudulent media Deceiving investors about the details of a merger with AOL. media Fraud & kickbacks - illegal marketing of AIDS wasting drug pharma Serostim and illegal remuneration/incentives paid discrimination to doctors to Discrimination - alleged racial, ethnic and gender retail against employees and job applicants. Accounting fraud retail International price fixing for the computer part, DRAM (dynamic tech random Damageaccess to landmemory). in the Niger Delta, Nigeria. energy Improper accounting, bid-rigging and skipped payments to state finance workers' compensation funds.Prudential Financial is not associated finance Deceptive trading (US based with UKacorporation plc) users to suffer heart Selling drug 'Vioxx'Prudential causing some pharma attacks/ischemic Exxon Valdez Oil strokes. Spill off coast of Alaska. Punitive damages energy reduced after appeal, see For paying "kickbacks andnotes. bribes to win contracts from Iraq's tech government in the United Nations oil-for-food program and for Bribing officials in Nigeria. defence Alleged groundwater contamination in New York wells from energy gasoline additivedestroying methyl tertiary butyl ether, or MTBE, a product Sham accounts, documents, tax evasion. finance Illegally marketing an anti-psychotic drug (zyprexa) for uses not pharma approved by the painkiller FDA. Misbranding Bextra, promoting it for unsuitable uses pharma Paying manufacturers to favour its products over those of rivals. tech Inaction in recalling faulty vehicles. cars Misleading reports regarding energy output on Native American energy tribalof lands in Colorado Gulf Mexico oil spiill energy Taking bribes on behalf of clients. Illegally marketed the anti-psychotic drug Seroquel for uses not approved as safe and effective by the US Food and Drug Administration. energy pharma

GlaxoSmithKline GlaxoSmithKline (2011)

Manufactured and sold contaminated drug products to Medicaid pharma and other government health plans. pharma Defrauded medicaid fraud, illegal sales practices related to nine drugs, and also product liability cases over its marketing of the diabetes drug Avandia. GSK paid doctors and manipulated medical research to promote the drug.

750 3,000

Johnson & Johnson (2012)* Barclays

Illegal marketing of its Risperdal & Invega (antipsychotic drugs), and Natrecor for congestive heart failure. Traders found to be illegally altering interest rates to generate profits for the bank and to appear more financially sound than they were. GSKs analysts found to be at risk of illegaly sharing non public information about upcoming research and ratings changes with other traders and a select group of investors Promoted the anti-seizure drug Depakote for uses unapproved by the U.S. Food and Drug Administration. Contracting scandals - sharing sensitive technology, exported technology without licenses.

pharma

2,200

Finance

450

Goldman Sachs

finance

22

Abbott Laboratories Boeing

pharma defence

1,500 849

Year
1984 1999 2000 2003 2003 2003 2003 2004 2004 2004 2004 2004 2004 2004 2004 2005 2005 2005 2005 2005 2005 2005 2005 2005 2005 2006 2006 2006 2007 2008 2008 2009 2009 2009 2009 2009 2009 2010 2010 2010 2010 2010

revenue
$bn 5.87 26.03 165.00 18.85 35.11 14.53 32.20 53.62 79.64 35.96 52.40 8.27 17.36 36.84 13.81 56.09 114.56 4.36 8.20 8.81 2.59 2.78 56.94 140.90 318.85 113.19 24.85 24.20 459.58 107.64 14.68 301.50 23.66 21.84 50.01 35.10 204.67 239.00 308.93 378.15 33.27

SQRT

fine as % of
year of fine 161.51% 20.25% 0.93% 11.69% -15.34% -6.53% -17.76% 2.82% 15.55% 1.41% 3.77% -36.37% 1105.69% 6.08% -36.23% N/A 4.10% 8.92% N/A -857.47% 191.54% 123.51% 2.70% 375.43% 3.19% 5.70% 11.39% 17.49% 146.34% 1.12% 19.56% 50.57% 0.54% 35.43% 32.79% 26.62% 32.95% 0.73% 0.04% 110.84% 0.23% 6.41%

fine as % of
year(s) of crime 145.51% 5.06% 0.27% 8.14% 1.32% -21.62% -1.03% 1.17% 9.59% 0.28% 0.84% 19.63% 190.74% 0.84% -23.53% 63.43% 1.37% 46.67% -11.73% -41.94% -13.09% 72.58% 3.73% -252.82% 1.92% 11.79% 2.67% 46.15% 1142.86% 13.31% 4.20% 156.06% 0.05% 1.81% 16.59% 3.79% 0.73% 0.01% 110.84% 0.07%

Years of
1999 1990-1999 1994 - 1999 1993-1996 1995-2001 1997-2001 1999 - 2002 1997-2000 2000-2001 1996 - 2003 1996-2004 1998 1994-1997 1993 1999-2001 1997 - 2000 1998 - 2003 1992 - 2002 1999-2001 1999-2000 1999 - 2002 1997-2001 2004 2001-2002 1999-2002 2000 1991 - 2004 2001-2003 2004 1989 1995-2007 1994 - 2004 2004-2009 2001 - 2006 1999-2001 2001 - 2005 2002-2007 2010 2007 2010

fine fined by
0.47 0.96 0.05 0.36 0.26 0.02 0.75 0.07 2.65 0.10 0.43 0.35 13.60 0.50 0.65 1.70 0.68 0.45 0.72 2.86 2.40 0.70 0.05 1.10 0.30 1.50 1.60 0.60 4.80 0.51 1.60 0.58 0.11 0.79 1.42 2.30 1.45 0.02 0.01 34.00 Government of India US Department of Justice and EU Commision Lawsuit Department of Health and Human Services DOJ Orange County jury Securities and Exchange Commission U.S. District Court in Seattle New York state Federal Reserve US Jury DOJ, Eastern District of Pennsylvania, Mass litigation,National multiple suits. European Commission for anti-competitive practices SEC The Federal Energy Regulatoryand Commission Securities Exchange Comission Mass litigation, multiple suits. US Department of Justice and SEC S.D. New York Minnesota State Board of Investments DOJ, District of Massachusetts U.S. District Court for the Northern District of SEC & Dutch Law Enforcement Agencies DOJ Nigerian National Assembly SEC SEC Separate federal and state lawsuits Supreme Court US & German courts SEC State of New York US Investigators Office of Consumer Litigation of the of Justice US Department European Commission for anti-competitive practices US Transport Dept

US Interior Department Various to cover compensation costs. 2002 - 2005 0.05 US Department of Justice 2.22% 2001-2006 0.52 DOJ and Health and Human Services Health Care Fraud Enforcement Action Team 0.75 Civil settlement 3.00 Mass litigation, multiple suits. DOJ

2010 2011

41.04 42.60

13.72% 36.66%

2.00% 2001 - 2005 3.20% 1994-2007

2012

2.20

2012

0.27%

2005 - 2009 0.45 FSA

2012

21.21 -

0.10

0.04%

2006-2011

0.02 Securities and Exchange Commission 1.50 US Justice Department 0.85 U.S. Departments of Justice, State, Defense and the Federal Trade and Securities Exchange commissions.

2012 19982001, 2003, 2006 335.68

38.73 7.50% 7.98 7.43%

6.53% 1998-2006 1998-2003

notes

net
$bn 0.29

revenue
$bn ? 9.50 102.18 603.92 26.87 352.72 27.10 146.33 211.63 223.85 148.70 262.98 8.08 50.63 215.02 49.49 192.43 206.87 20.82 7.52 68.74 22.93 5.46 2.02 110.67 105.72 191.51 583.82 53.82 7.97 96.08 1,034.02 135.82 2,167.08 209.99 32.41 203.60 204.67 852.20 308.93 1,064.78 8.11 124.76

500 million in US, 462 in Europe. Years of crime taken from another unpaid workers case, details of Colorado case undisclosed. accounts for astra zeneca merger date back to 1995 occurred April 1999. zeneca plc made zoladex... used their r/p 1993, 1994 Cross referenced DEM exchange rates with EURO on multiple Annual Reports to ensure 1995-1997 #'s were correct for YoC. Net Income loss 2003 was because jury awarded 934, finally settled 23. "The settlement isin the latest fallout fromof a impairment U.S. Supreme Court decision in April that is being interpreted lower courts as limiting Filed for bankruptcy in 2002 following discrepancies with by accounting. Years of fine profits is last recorded from 2002. Worldcom operating at a loss for years running upto multiple fines

4.75 5.38 3.04 -1.67 -0.35 -4.22 2.57 17.05 7.08 11.40 -0.95 1.23

(now merck) "reports state that over all, Wyeth has paid $13.6 billion to settle fen-phen claims" Years of crime 497m relate euros to in year 2004when problem was suspected and year when drug was pulled. 8.17 -1.79 Company declared bankruptcy after crimes revealed in 2001, re-emerged in 2004, fined in 2005. 16.47 $448 million total paid out. 5.02 The Rigas family started co-borrowing in 1996, really picked up in 1999. Company filed bankruptcy 2002, dissolved 19992530.7. as beginning date of crime as 36.213 2nd 15 quarters,June not 16. Profit in 20052006. wouldChose have been Revenue / Profit 2000 / -0.33 -4.384 / -2.446 2001 +1999 200232.525 revenues as AOL Time Warner 1.25 (now merck) As it was acquired was hard to find primary sources for R/P, ended up using secondary sources less attorney's cost 'breadcrumbs' ands fees, they estimated on their 2004 10-k filings it would be 1.85 $40.9m, afjustice states 50. 0.29 9.40 26.30 14.05 2006 - consolidated net income Years of crimes 2004. Punitive damages reduced from $5 billion to only $507.5 million after appeals that took 45.22 place nearly 20 years after spill. 8.18 1.15 19.28 2.22 need 2005 r/p 1.06bn euros, 948m Used historical conversion rates from Japanese Yen. * Added fine back on to profits and then re-calculated.

0.57

3.43 3.28

4.33 8.64 4.40 2.26 14.00 30.68 20.47

5.47 8.18

173.87 377.27

J&J has agreed to up to $2.2 billion ($600m criminal penalty) amounts to less than 10 percent of the Risperdal sales or $24 billion since 2003. antipsychotic drug industry totalled about $16 billion in sales in 2010 Used 2011 for years of fine financials

191.04

201.25

2012 fine, R/P Not available yet

219.02

2012 fine, R/P Not available yet

11.32

150.40 328.21

net
$bn ? 0.32 19.01 18.77 4.36 19.48 -0.11 -72.63 6.19 27.65 36.10 51.43 1.76 7.13 59.30 -2.76 2.68 49.44 0.96 -6.09 -6.83 -18.33 0.97 1.34 -0.44 15.62 12.72 59.87 1.30 0.42 3.81 38.12 0.37 206.07 43.53 8.56 38.25 2.26 55.90 30.68 67.74

industry
Chemicals Vitamin/Pharma ceutical Retail Pharmaceutical Pharmaceutical Electronics Communications Transport Banking Banking Pharmaceutical Pharmaceutical Pharmaceutical Computing Telecom Energy Banking Insurance Health Telecom Computing Entertainment Pharmaceutical Retail Food Electronics Energy Insurance Insurance Pharmaceutical Energy Electronics Engineering Energy Banking Pharmaceutical Pharmaceutical Computing Auto Energy Energy Energy 23.38 Pharmaceutical

Chief sources
Time Magazine, LA Times, Get Filings Accutaneaction, Roche New York Times, University of New York Times, Edgar-Online, New York Times, Bayer, Wiley New York Times, LA Times,Get BBC, filingsGet Guardian, Filings Komonews Boeing, LA Times, Citigroup New York Times, UBS New York Times, Pfizer, Buck of Justice, Department Washington Post, New York Times, Corporate IR BBC, Microsoft Washington Post, Porticus, LA TimesMorning Star New York Times, BankYork of America New Times, University of Houston, New York Times, Yahoo - Biz Securities Exchange Commission, New York Times, Get Filings Red Orbit, PRNewsWire, AFjustice, CorporateIR CNN, Ahold Department of Justice, Scribd, Samsung Guardian, The Times, Shell York Times, AIG, New Securities Exchange Washington Post, Prudential Boston Herald, Merck NowPublic, New York Times, Thomson Washington Post, Siemens Bloomberg, Halliburton, Getfilings Wall Street Journal, Thomson, UBS ExxonMobil Guardian, MSNBC, Lilly Investor Relations Guardian, New York Times, Pfizer BBC, Intel Guardian BBC, Department of Interior, BP Guardian, BP Telegraph, Shell

Source Links

http://en.wikipedia.org/wiki/Bhopal_disaster#Compensation_from_Union_Carbide http://www.accutaneaction.com/Frauds/roche_finc_frauds.html http://www.endgame.org/corpfines4.html http://www.nytimes.com/2003/06/21/business/21CANC.html http://www.quitamhelp.com/static/stories/bayer-glaxo.html http://www.endgame.org/corpfines1.html http://news.bbc.co.uk/1/hi/business/3053068.stm http://www.endgame.org/corpfines1.html http://www.citigroup.com/citi/investor/sec.htm http://www.endgame.org/corpfines4.html http://www.nytimes.com/2004/05/14/business/pfizer-to-pay-430-million-over-promoting http://www.endgame.org/corpfines3.html http://www.endgame.org/corpfines4.html http://news.bbc.co.uk/1/hi/business/8047546.stm http://www.endgame.org/corpfines3.html http://articles.latimes.com/2005/feb/01/business/fi-ferc1 http://www.nytimes.com/2005/02/09/business/worldbusiness/09iht-boa.html http://www.endgame.org/corpfines4.html http://www.nytimes.com/2005/04/26/business/media/26settle.html?_r=1 http://www.endgame.org/corpfines1.html http://www.nytimes.com/2005/08/04/business/media/04place.html http://www.endgame.org/corpfines3.html http://afjustice.com/ http://www.endgame.org/corpfines1.html http://www.endgame.org/corpfines3.html http://business.timesonline.co.uk/tol/business/markets/africa/article734579.ece http://www.nytimes.com/2006/02/06/business/06insure.html http://www.endgame.org/corpfines3.html http://bostonherald.com/business/healthcare/view/Merck_to_pay__4_85B_Vioxx_settl http://www.nowpublic.com/environment/exxon-valdez-oil-spill-settlement-exxon-pay-50 http://www.washingtonpost.com/wp-dyn/content/article/2008/12/15/AR2008121502926 http://www.bloomberg.com/apps/news?pid=newsarchive&sid=a5SIJHgE3rXA http://online.wsj.com/article/SB125598438080394827.html?mod=rss_whats_news_us http://www.guardian.co.uk/business/2009/mar/01/swiss-banks-anonymity-ubs http://www.msnbc.msn.com/id/28677805/ns/health-health_care/t/eli-lilly-settles-zyprex http://www.guardian.co.uk/business/2009/sep/02/pfizer-drugs-us-criminal-fine http://news.bbc.co.uk/1/hi/business/8047546.stm http://www.guardian.co.uk/business/2010/apr/19/toyota-pay-record-fine-safety http://www.bbc.co.uk/news/10461597 http://www.guardian.co.uk/environment/2010/jun/14/gulf-oil-spill-34bn-fines

http://www.telegraph.co.uk/finance/newsbysector/energy/oilandgas/8111277/Shell-to-p

Department of Justice, http://www.justice.gov/opa/pr/2010/April/10-civ-487.html AstraZeneca

37.48 Pharmaceutical 93.77 Pharmaceutical

CBS News, Get Nick http://www.getnicklaw.com/media/gsk_media_popup.html Law New York Times, GSK http://www.justice.gov/opa/pr/2012/July/12-civ-842.html

Pharmaceutical

Bloomberg, Reuters

http://www.bloomberg.com/news/2012-06-11/j-j-said-to-pay-2-2-billion-to-end-risperda

164.40

Finance

Guardian

2012

49.64 Banking

22.98 Pharmaceutical 11.42 Transport

Securities Exchange http://www.sec.gov/news/press/2012/2012-61.htm Commission, Goldman Sachs Department of Justice, http://www.justice.gov/opa/pr/2012/May/12-civ-585.html Get Filings Endgame, Boeing http://www.endgame.org/corpfines1.html

http://www.time.com/time/magazine/article/0,9171,959794,00.html http://www.referenceforbusiness.com/history/Ul-Vi/Union-Carbide-Corporation.htm http://webcache.googleusercontent.com/search?q=cache:NQzeVA_xyNkJ:www.roche.com/gb99fde.xls+roche+1999+revenue&cd=3&hl=en& http://www.roche.com/gb99e.pdf http://www.nytimes.com/2002/06/25/us/suits-say-wal-mart-forces-workers-to-toil-off-the-clock.html?pagewanted=all&src=pm http://www.wisconsin.edu/tfunds/walmart1204a.htm http://google.brand.edgar-online.com/EFX_dll/EDGARpro.dll?FetchFilingHtmlSection1?SectionID=427128-38512-43874&SessionID=RRKjH http://www.astrazeneca.com/Investors/financial-information/Financial-results http://www.nytimes.com/2003/04/17/business/17DRUG.html?pagewanted=all http://www.bayer.com/en/en-ar-complete.pdfx http://www.getfilings.com/o0000950134-04-008798.html#104 http://www.getfilings.com/o0000891618-01-501490.html http://www.guardian.co.uk/business/2002/aug/09/corporatefraud.worldcom2 http://www.getfilings.com/o0001193125-04-039709.html#tx43272_7 http://www.boeing.com/companyoffices/financial/finreports/annual/06annualreport/assets/Boeing_06AR_00.pdf http://www.komonews.com/news/archive/4169196.html http://articles.latimes.com/2004/may/11/business/fi-citi11 http://www.nytimes.com/2004/05/11/business/ubs-fined-100-million-over-trading-of-dollars.html http://www.ubs.com/global/en/about_ubs/investor_relations/annualreporting/archiv http://www.pfizer.com/investors/financial_reports/financial_report_2004.jsp http://buck.com/annual_report?idx=P&co=PFE&yr=97&nam=DEMO&pw=DEMO http://www.quitamhelp.com/static/stories/schering.html http://www.justice.gov/opa/pr/2004/July/04_civ_523.htm http://www.nytimes.com/2005/02/12/business/12law.html?scp=11&sq=Wyeth%20fine%20Fen%20Phen&st=Search http://library.corporate-ir.net/library/78/781/78193/items/141903/AR04.pdf http://www.microsoft.com/msft/ar04/nonflash/10k_dl_main.html http://www.washingtonpost.com/wp-dyn/articles/A53148-2004Oct21.html http://en.wikipedia.org/wiki/Accounting_scandals

http://investor.bankofamerica.com/phoenix.zhtml?c=71595&p=irol-reportsannual https://docs.google.com/viewer?a=v&q=cache:IKWsl_c77ZwJ:www.law.uh.edu/healthlaw/perspectives/%28ST%2911thCirc http://www.nytimes.com/2005/07/12/business/12health.html?scp=3&sq=Wellpoint%20doctors&st=Search http://www.nytimes.com/2004/02/01/magazine/the-company-they-kept.html?pagewanted=1&pagewanted=print http://biz.yahoo.com/ic/15/15879.html http://sec.gov/Archives/edgar/data/1468516/000095015709000443/ex99-1.htm#summary http://www.kronemyer.com/Warner%20Music%20Group/AOL%20Time%20Warne http://www.getfilings.com/o0000930661-01-000789.html http://www.getfilings.com/o0000950144-02-011682.html#009 http://www.redorbit.com/news/health/331815/serono_labs_pleads_guilty_to_the_illegal_marketing_of_aids/ http://www.prnewswire.com/news-releases/seronos-2005-adjustedi-eps-increased http://library.corporate-ir.net/library/61/617/61701/items/198310/05AnnualReport.pdf http://en.wikipedia.org/wiki/Ahold#History http://money.cnn.com/magazines/fortune/global500/2007/snapshots/7908.html http://www.scribd.com/doc/269317/Samsung-Annual-Report-2005 http://www.justice.gov/atr/public/press_releases/2005/212002.htm http://www.shell.com/home/content/investor/financial_information/faoi/dir_faoi_index.html http://www.guardian.co.uk/world/2006/feb/25/oil.business http://www.aigcorporate.com/investors/financial_reports.html#05 http://www.sec.gov/news/press/2006-19.htm http://www.washingtonpost.com/wp-dyn/content/article/2006/08/28/AR2006082801181.html http://www3.prudential.com/annualreport/report2007/annual/images/Prudential_AR http://www.merck.com/investors/financials/annual-reports/home.html http://www.nytimes.com/1990/01/25/business/company-earnings-profits-off-at-chevron-and-exxon.html?pagewanted=all http://thomson.mobular.net/thomson/7/2946/4183/ http://www.siemens.com/annual/08/en/financial_information.htm http://www.siemens.com/investor/pool/en/investor_relations/downloadcenter/gb200 http://finance.yahoo.com/q/is?s=hal+Income+Statement&annual http://ir.halliburton.com/phoenix.zhtml?c=67605&p=irol-reportsAnnual http://thomson.mobular.net/thomson/7/2946/4183/ http://ir.exxonmobil.com/phoenix.zhtml?c=115024&p=irol-reportsAnnual http://www.ubs.com/global/en/about_ubs/investor_relations/annualreporting/2009.html http://afp.google.com/article/ALeqM5jTfwAG7pDZAUUS8_feZQgnnHAeaQ http://investor.lilly.com/sec.cfm?SortOrder=Type%20Ascending&DocType=&DocTypeExclude=&Year= http://www.pfizer.com/investors/financial_reports/financial_reports.jsp http://www.guardian.co.uk/business/2009/sep/02/pfizer-drugs-us-criminal-fine http://www.intc.com/intelAR2009/introduction/financial/ http://www.intc.com/results.cfm http://www.toyota-global.com/investors/ir_library/annual/index.html http://www.bp.com/extendedsectiongenericarticle.do?categoryId=9021229&contentId=7039276 http://www.doi.gov/news/pressreleases/Interior-Issues-5-pt-2-M-Civil-Penalty-to-BP http://www.bp.com/extendedsectiongenericarticle.do?categoryId=9021229&contentId=7039276 http://www.bp.com/extendedsectiongenericarticle.do?categoryId=9039692&conten http://www.dutchnews.nl/news/archives/2010/11/shell_others_settle_nigerian_b.php http://reports.shell.com/annual-review/2010/servicepages/welcome.php

http://www.astrazeneca.com/Investors/financial-information/Financial-results http://www.astrazeneca.com/cs/Satellite?blobcol=urldata&blobheader=application%

http://www.cbsnews.com/2100-18560_162-7195247.html http://www.nytimes.com/2011/11/04/business/glaxo-to-pay-3-billion-in-avandia-settlement.html http://www.nytimes.com/2011/01/18/business/18drug.html?_r=1

http://www.reuters.com/article/2012/06/08/johnsonandjohnson-risperdal-idUSL1E8H8HBQ20120608

http://www.guardian.co.uk/business/2012/jun/27/barclays- http://www.guardian.co.uk/business/2012/jun/27/barclayschief-bob-diamond-bonus-fine other-banks-interest-rates-fsa?intcmp=239 http://www.goldmansachs.com/investor-relations/financials/archived/annual-reports/index.html

http://www.getfilings.com/comp/k0000001800.html

http://boeing.com/companyoffices/financial/finreports/annual/99annualreport/toc.html http://boeing.com/companyoffices/financial/finreports/annual/01annualreport/2001

http://articles.latimes.com/1986-04-08/business/fi-25458_1_union-carbide-plans http://www.getfilings.com/o0000912057-02-010680.html#toc_di1727_3

http://investors.walmartstores.com/phoenix.zhtml?c=112761&p=irol-reportsannual http://www.nytimes.com/2002/06/25/us/suits-say-wal-mart-forces-workers-to-toil-of http://www.astrazeneca.com/cs/Satellite?blobcol=urldata&blobheader=application%2Fpdf&blobheadername1=Content-Disposition&blobhead http://www.wiley.com/college/kieso/0471363049/dt/analysttool/realco/bayer/abschluss_rechnung_en.html http://www.bayer.com/en/en_ar_complete_2004.pdfx http://www.nytimes.com/2003/11/29/business/company-news-flextronics-agrees-to-pay-23-million-in-contract-suit.html http://articles.latimes.com/2003/nov/27/business/fi-beckman27 39709.html#tx43272_7

estor_relations/annualreporting/archive.html E&yr=97&nam=DEMO&pw=DEMO http://media.corporate-ir.net/media_files/IROL/89/89839/reports/sgp_ar04a.pdf http://www.consumeraffairs.com/news04/claritin.html http://www.nytimes.com/2005/02/17/business/17wyeth.html?scp=2&sq=Wyeth+fen+phen&st=nyt http://www.porticus.org/bell/pdf/Qwest_AR2005.pdf http://en.wikipedia.org/wiki/Qwest#Accounting_and_insider_trading_irregularities

http://ir.wellpoint.com/phoenix.zhtml?c=130104&p=irol-reportsannual

http://securities.stanford.edu/1024/AOL02-01/ http://www.washingtonpost.com/wp-dyn/articles/A53801-2005Mar21.html 11682.html#009 http://www.prnewswire.com/news-releases/serono-and-pfizer-to-co-promote-multiple-sclerosis-treatment-rebifr-in-the-united-states-76134692 http://www.prnewswire.co.uk/news-releases/serono-reports-strong-growth-in-q1-20

https://www.ahold.com/Financial-information/Annual-reports/Annual-Report-2002.htm#!/Financial-information/Annual-reports/Annual-Reporthttp://www.washingtonpost.com/wp-dyn/content/article/2005/11/28/AR2005112800 http://www.samsung.com/us/aboutsamsung/ir/financialinformation/annualreport/downloads/2002/eng_Financial_Overview2002.pdf http://www.samsung.com/us/aboutsamsung/ir/financialinformation/annualreport/do http://www.shell.com/home/content/investor/financial_information/annual_reports_and_publications/archive/2006/ http://www3.prudential.com/annualreport/report2004/2004/annual/Annual_Report.pdf

http://www.siemens.com/annual/07/pool/download/pdf/e07_00_gb2007.pdf http://www.siemens.com/investor/pool/en/investor_relations/financial_publications/ http://www.getfilings.com/comp/k0000045012.html 5024&p=irol-reportsAnnual http://www.ubs.com/global/en/about_ubs/media/emea/annualreporting/archive.html http://www.nytimes.com/2009/09/03/business/03health.html?_r=1

or-Issues-5-pt-2-M-Civil-Penalty-to-BP-America-for-False-Reporting-on-Tribal-Lands.cfm ticle.do?categoryId=9039692&contentId=7072683

ervicepages/welcome.php

bcol=urldata&blobheader=application%2Fpdf&blobheadername1=Content-Disposition&blobheadername2=MDT-Type&blobheadervalue1=inline%3B+filen

http://www.gsk.com/investors/reps11/GSK-Annual-Report-2011.pdf http://www.gsk.com/investors/reps04/annual-report-2004.pdf

http://www.searcymasstort.com/blog/2012/04/06/antipsychotic-drugs-overused-heart-attack-risk-for-elderly-patients/

http://group.barclays.com/about-barclays/investorrelations/financial-results-and-publications/annualreports

http://www.boeing.com/companyoffices/financial/finreports/annual/03annualreport/op_hilights.html http://www.boeing.com/companyoffices/financial/finreports/annual/06annualreport/

http://www.umass.edu/sts/pdfs/Bhopal_AChrono.pdf

say-wal-mart-forces-workers-to-toil-off-the-clock.html?pagewanted=all&src=pm name1=Content-Disposition&blobheadername2=MDT-Type&blobheadervalue1=inline%3B+filename%3D1995---1997.pdf&blobheadervalue2=abinary%3B

ess/fi-beckman27

http://www.contractormisconduct.org/ass/contractors/178/cases/1266/1798/schering-plough-claritin-fca-civ-and-crim_pr.pdf http://www.washingtonpost.com/wp-dyn/content/article/2006/08/29/AR2006082901

http://quote.morningstar.com/stock-filing/Annual-Report/2001/12/31/t.aspx?t=XNYS:Q&ft=10-K405&d=c0a6b3539d02e644

es/A53801-2005Mar21.html

http://www2.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/01-10-2001/0001400839&EDATE= http://www.evaluatepharma.com/Universal/View.aspx?type=Story&id=1734

https://www.ahold.com/#!/Financial-information/Annual-reports.htm r/financialinformation/annualreport/downloads/2000/eng_digital_e_company.pdf

http://www.siemens.com/investor/pool/en/investor_relations/financial_publications/annual_reports/GB2002_d_oS_1321349.pdf http://web.lib.hse.fi/FI/yrityspalvelin/pdf/1996/esiemens.pdf

e&blobheadervalue1=inline%3B+filename%3DFigures.pdf&blobheadervalue2=abinary%3B+charset%3DUTF-8&blobkey=id&blobtable=MungoBlobs&blobw

http://www.gsk.com/investors/reps02/annual-report-2002.pdf http://www.gsk.com/investors/reps00/annual-report-2000.pdf

cial/finreports/annual/06annualreport/assets/Boeing_06AR_00.pdf

7.pdf&blobheadervalue2=abinary%3B+charset%3DUTF-8&blobkey=id&blobtable=MungoBlobs&blobwhere=1285616469787&ssbinary=true

http://buck.com/annual_report?idx=s&co=SGP&pg=003&res=l&yr=98&np=40&nam=DEMO&pw=DEMO

c0a6b3539d02e644

http://www.thefreelibrary.com/Ares-Serono+Sales+Increase+by+6.3%25+to+US$+918+Million+in+1998.-a053591191 http://www.mult-

http://www.siemens.com/investor/pool/en/investor_relations/downloadcenter/gb1998_d_1365091.pdf

key=id&blobtable=MungoBlobs&blobwhere=1285616468942&ssbinary=true

http://www.wikinvest.com/stock/GlaxoSmithKline_(GSK)/Data/Revenue/1998 http://www.wikinvest.com/stock/GlaxoSmithKline_(GSK)/Data/Net_Margin/1998

87&ssbinary=true

(GSK)/Data/Net_Margin/1998

Barclays $299m - July 2013 http://www.guardian.co.uk/business/2013/jul/17/us-energy-